logo
Select company
Select metric
14.82%EBIT Margin
VS
Market
67
Sector
85
Industry
88
History
89
$ 1.86Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ 9.18M14.82%$ 61.95M
3/31/2025$ 5.83M9.76%$ 59.76M
12/31/2024$ 5.22M9.77%$ 53.4M
9/30/2024$ -9.04M-19.8%$ 45.67M
6/30/2024$ -14.45M-37.96%$ 38.05M
3/31/2024$ 8.41M14.1%$ 59.65M
12/31/2023$ 10.46M15.97%$ 65.49M
9/30/2023$ 14.74M23.17%$ 63.63M
6/30/2023$ 12.87M19.08%$ 67.46M
3/31/2023$ -12.79M-31.09%$ 41.14M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at 3.39%.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average EBIT % has been -11.16%.
  • The median EBIT % for PROTALIX BIOTHERAPEUTICS INC during this period was -15.26%
  • PROTALIX BIOTHERAPEUTICS INC reached its highest EBIT % over the past 5 years at 23.17%.
  • The lowest EBIT % recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe -53.36%

PROTALIX BIOTHERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CSBR : CHAMPIONS ONCOLOGY INC 5.05%THTX : THERATECHNOLOGIES INC 9.56%BDTX : BLACK DIAMOND THERAPEUTICS INC 20.63%SPRO : SPERO THERAPEUTICS INC -110.34%ENTA : ENANTA PHARMACEUTICALS INC -133%CELU : CELULARITY INC -147.39%IVVD : INVIVYD INC -238.33%DOMH : DOMINARI HOLDINGS INC -36.01%SGMO : SANGAMO THERAPEUTICS INC -77.72%ALEC : ALECTOR INC -142.04%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: EBIT [ $ 2.07M ] / Revenues [ $ 61.16M ]
(=) EBIT % [ 3.39% ]

PLX - EBIT Margin, Last 5 years

-53.36%

Minimum

Dec 31, 2021

23.17%

Maximum

Sep 30, 2023

-11.16%

Average

-15.26%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%